International Drug & Explosives Detection Firm IDenta Corp. Updates on 2009 San Diego Explosives Detection Symposium and Worksh
International Drug & Explosives Detection Firm IDenta Corp. Updates on 2009
International Drug & Explosives Detection Firm IDenta Corp. Updates on 2009 San Diego Explosives Detection Symposium and Workshop
JERUSALEM, Dec. 21 /PRNewswire-FirstCall/ -- IDenta Corp. (Pink Sheets: IDTA) As a result of the 2009 Explosives Detection Symposium and Workshop held in San Diego (press release of Dec. 1), IDenta is happy to report that the company is in the final stage of signing an agreement with an American federal agency to supply an initial order of 100,000 (one hundred thousand) explosive detection kits. In the last couple of weeks, IDenta has been in constant contact with the agency to close the technical and logistics issues.
IDenta Corp. CEO Yaacov Shoham commented, "This order, which we expect to sign in the very near future, will be, in our opinion, the first of many orders from other American federal agencies and from other countries. We expect these orders due to the superiority of the IDenta Alert explosive detection kits."
The 2009 San Diego Explosives Detection Symposium and Workshop was a huge success and requests for information and samples of IDenta explosive kits have been enormous.
Some of the requests are from very important American law enforcement or military agencies like: FBI-Quantico, Department of Defense, Homeland Security, Analytical Microscopy Group National Institute of Standards and Technology, NavAIR, Naval Air Warfare Center Weapons Division, 930 CAST, US Army for Afghanistan and Iraq, Office of the Deputy Sec of Defense, US Customs and Border Protection, Bureau of Alcohol, Tobacco, Firearms and Explosives, etc.
ABOUT IDENTA
Since 2003, IDenta Corporation has been recognized as a worldwide leader in the development of proprietary on-site drug, drug precursor and explosive detection kits. IDenta develops, manufactures and distributes products for both the professional and civil markets which consistently pass the highest qualifications and testing procedures of law enforcement and security agencies around the world.
Information concerning IDenta's entire product line may be found at [ www.IDenta.biz ]
DISCLAIMER
Certain of the statements contained herein may be, within the meaning of the federal securities laws, "forward-looking statements" that are subject to risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. These forward-looking statements are based on management's expectations as of the date hereof, and the company does not undertake any responsibility to update any of these statements in the future.
For Investor Relations, lobbying interests or information concerning IDenta's products internationally or the development of new chemical detectors, contact: Yaacov Shoham, IDenta Corp., CEO, Tel: +972-52-6554487, [ fpi@drugsdetector.com ], [ www.identa.biz ].
For information about the Accutest® - IDenta products in the US, please contact: Mr. Eyal Golan, COO, JANT PHARMACAL CORPORATION, 16255 Ventura Blvd. #505, Encino, CA 91436, Toll Free: 800-676-5565, 661-478-0582 (mobile), golan@accutest.net, [ www.accutestidenta.net ].
SOURCE IDenta Corp.